At BIO-Europe Spring 2025, Avance Clinical’s key representatives, Alex Kavros and Mike Watson, will be available to discuss how the company’s unique capabilities can accelerate your biotech’s clinical development. Leveraging the Australian Advantage, Avance Clinical offers rapid ethics approval, no IND requirement, and a 43.5% R&D tax rebate, providing biotechs with an accelerated pathway to clinical
success.
Dr. Alex Kavros, Executive Vice President of Scientific & Regulatory Affairs, who is located in Switzerland, is a seasoned expert in global drug development, regulatory science, and clinical operations. With extensive experience across biologics, small molecules, and advanced therapies, Alex has led clinical and regulatory programs at top pharmaceutical and CRO organizations, ensuring successful trial execution and regulatory approvals.
Mike Watson, Director of Business Development, based in the United States, brings over 13 years of experience in clinical research and business development, specializing in early and late-phase trials. Located in North Carolina, Mike has a deep understanding of the clinical trial landscape and works closely with biotech companies to develop tailored solutions for their drug development programs.
Avance Clinical’s in-house ClinicReady team of scientific and regulatory experts ensures seamless early-phase study execution, setting the foundation for successful transitions into later phases. This support helps biotechs demonstrate safety, achieve proof of concept, and progress efficiently toward commercialization.
With a global footprint spanning Australia, New Zealand, Asia, North America, and Europe, Avance Clinical enables biotech sponsors to transition seamlessly from early to late-phase clinical trials. The company’s multi-regional expertise covers key therapeutic areas, including oncology, CNS, rare diseases, and infectious diseases, ensuring high-quality trial execution and regulatory-ready data.
Don’t miss the opportunity to meet with Alex Kavros and Mike Watson at BIOEurope Spring 2025 to explore how Avance Clinical can support your biotech’s clinical development journey. Book a meeting today!
